CME and the NYSE are urging U.S. regulators to regulate Hyperliquid, citing concerns about market manipulation and sanctions circumvention.

PANews reported on May 15 that, according to Bloomberg, the CME Group and the New York Stock Exchange are pushing U.S. regulators to strengthen oversight of Hyperliquid, with key concerns including market manipulation, lack of transparency, and potential sanctions circumvention risks.

Share to:

Author: PA一线

This content is for market information only and is not investment advice.

Follow PANews official accounts, navigate bull and bear markets together
PANews APP
Bridgewater Associates released its latest 13F filing, announcing it increased its holdings in chip stocks and reduced its holdings in software stocks.
PANews Newsflash